|
|
||||||||
Journal of General Virology, Vol 78, 1907-1911, Copyright © 1997 by Society for General Microbiology
ARTICLES |
M Saifuddin, T Hedayati, JP Atkinson, MH Holguin, CJ Parker and GT Spear
Department of Immunology/Microbiology, Rush University, Chicago, IL 60612, USA. msaifudd@rush.edu
Human immunodeficiency virus type 1 (HIV-1) can be either resistant or sensitive to complement-mediated destruction depending on the host cells. Incorporation of different levels of host cell CD46, CD55 and CD59 may account for this differential sensitivity to complement. However, it has not been determined whether CD46, CD55 and CD59 can all be incorporated at levels which protect virions. To determine whether each of these proteins can protect HIV-1, virions were derived from CHO cells expressing either human CD46, CD55 or CD59. Virions were shown to incorporate both glycosyl phosphatidylinositol (GPI)-anchored CD55 and CD59 as well as transmembrane CD46. Importantly, all three virus preparations were significantly more resistant to complement lysis than control virus. This study demonstrates that HIV-1 incorporates both transmembrane and GPI-anchored complement control proteins from host cells and that both types of protein increase complement resistance of virus.
This article has been cited by other articles:
![]() |
J. B. Johnson, K. Grant, and G. D. Parks The Paramyxoviruses Simian Virus 5 and Mumps Virus Recruit Host Cell CD46 To Evade Complement-Mediated Neutralization J. Virol., August 1, 2009; 83(15): 7602 - 7611. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Girgis, B. C. DeHaven, X. Fan, K. M. Viner, M. Shamim, and S. N. Isaacs Cell Surface Expression of the Vaccinia Virus Complement Control Protein Is Mediated by Interaction with the Viral A56 Protein and Protects Infected Cells from Complement Attack J. Virol., May 1, 2008; 82(9): 4205 - 4214. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Bouhlal, N. Chomont, M. Requena, N. Nasreddine, H. Saidi, J. Legoff, M. D. Kazatchkine, L. Belec, and H. Hocini Opsonization of HIV with Complement Enhances Infection of Dendritic Cells and Viral Transfer to CD4 T Cells in a CR3 and DC-SIGN-Dependent Manner J. Immunol., January 15, 2007; 178(2): 1086 - 1095. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. B. Spiller, L. Mark, C. E. Blue, D. G. Proctor, J. A. Aitken, A. M. Blom, and D. J. Blackbourn Dissecting the Regions of Virion-Associated Kaposi's Sarcoma-Associated Herpesvirus Complement Control Protein Required for Complement Regulation and Cell Binding. J. Virol., April 1, 2006; 80(8): 4068 - 4078. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kolegraff, P. Bostik, and A. A. Ansari Characterization and role of lentivirus-associated host proteins. Experimental Biology and Medicine, March 1, 2006; 231(3): 252 - 263. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Goluszko and B. Nowicki Membrane Cholesterol: a Crucial Molecule Affecting Interactions of Microbial Pathogens with Mammalian Cells Infect. Immun., December 1, 2005; 73(12): 7791 - 7796. [Full Text] [PDF] |
||||
![]() |
S. J. D. Neil, A. McKnight, K. Gustafsson, and R. A. Weiss HIV-1 incorporates ABO histo-blood group antigens that sensitize virions to complement-mediated inactivation Blood, June 15, 2005; 105(12): 4693 - 4699. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Cantin, S. Methot, and M. J. Tremblay Plunder and Stowaways: Incorporation of Cellular Proteins by Enveloped Viruses J. Virol., June 1, 2005; 79(11): 6577 - 6587. [Full Text] [PDF] |
||||
![]() |
M. M. I. Aasa-Chapman, S. Holuigue, K. Aubin, M. Wong, N. A. Jones, D. Cornforth, P. Pellegrino, P. Newton, I. Williams, P. Borrow, et al. Detection of Antibody-Dependent Complement-Mediated Inactivation of both Autologous and Heterologous Virus in Primary Human Immunodeficiency Virus Type 1 Infection J. Virol., March 1, 2005; 79(5): 2823 - 2830. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Magre, Y. Takeuchi, G. Langford, A. Richards, C. Patience, and R. Weiss Reduced Sensitivity to Human Serum Inactivation of Enveloped Viruses Produced by Pig Cells Transgenic for Human CD55 or Deficient for the Galactosyl-{alpha}(1-3) Galactosyl Epitope J. Virol., June 1, 2004; 78(11): 5812 - 5819. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Nguyen, A. Booth, S. J. Gould, and J. E. K. Hildreth Evidence That HIV Budding in Primary Macrophages Occurs through the Exosome Release Pathway J. Biol. Chem., December 26, 2003; 278(52): 52347 - 52354. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. de Gassart, C. Geminard, B. Fevrier, G. Raposo, and M. Vidal Lipid raft-associated protein sorting in exosomes Blood, December 15, 2003; 102(13): 4336 - 4344. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Van de Walle, H. W. Favoreel, H. J. Nauwynck, and M. B. Pensaert Antibody-induced internalization of viral glycoproteins and gE-gI Fc receptor activity protect pseudorabies virus-infected monocytes from efficient complement-mediated lysis J. Gen. Virol., April 1, 2003; 84(4): 939 - 947. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pausa, V. Pellis, M. Cinco, P. G. Giulianini, G. Presani, S. Perticarari, R. Murgia, and F. Tedesco Serum-Resistant Strains of Borrelia burgdorferi Evade Complement-Mediated Killing by Expressing a CD59-Like Complement Inhibitory Molecule J. Immunol., March 15, 2003; 170(6): 3214 - 3222. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. W. Favoreel, G. R. Van de Walle, H. J. Nauwynck, and M. B. Pensaert Virus complement evasion strategies J. Gen. Virol., January 1, 2003; 84(1): 1 - 15. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bavari, C. M. Bosio, E. Wiegand, G. Ruthel, A. B. Will, T. W. Geisbert, M. Hevey, C. Schmaljohn, A. Schmaljohn, and M. J. Aman Lipid Raft Microdomains: A Gateway for Compartmentalized Trafficking of Ebola and Marburg Viruses J. Exp. Med., March 4, 2002; 195(5): 593 - 602. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Takefman, G. T. Spear, M. Saifuddin, and C. A. Wilson Human CD59 Incorporation into Porcine Endogenous Retrovirus Particles: Implications for the Use of Transgenic Pigs for Xenotransplantation J. Virol., February 15, 2002; 76(4): 1999 - 2002. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Esser, D. R. Graham, L. V. Coren, C. M. Trubey, J. W. Bess Jr., L. O. Arthur, D. E. Ott, and J. D. Lifson Differential Incorporation of CD45, CD80 (B7-1), CD86 (B7-2), and Major Histocompatibility Complex Class I and II Molecules into Human Immunodeficiency Virus Type 1 Virions and Microvesicles: Implications for Viral Pathogenesis and Immune Regulation J. Virol., July 1, 2001; 75(13): 6173 - 6182. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Friedman, L. Wang, M. K. Pangburn, J. D. Lambris, and J. Lubinski Novel Mechanism of Antibody-Independent Complement Neutralization of Herpes Simplex Virus Type 1 J. Immunol., October 15, 2000; 165(8): 4528 - 4536. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Saifuddin, M. L. Hart, H. Gewurz, Y. Zhang, and G. T. Spear Interaction of mannose-binding lectin with primary isolates of human immunodeficiency virus type 1 J. Gen. Virol., April 1, 2000; 81(4): 949 - 955. [Abstract] [Full Text] |
||||
![]() |
D. H. Nguyen and J. E. K. Hildreth Evidence for Budding of Human Immunodeficiency Virus Type 1 Selectively from Glycolipid-Enriched Membrane Lipid Rafts J. Virol., April 1, 2000; 74(7): 3264 - 3272. [Abstract] [Full Text] |
||||
![]() |
S. D. Lawn, B. D. Roberts, G. E. Griffin, T. M. Folks, and S. T. Butera Cellular Compartments of Human Immunodeficiency Virus Type 1 Replication In Vivo: Determination by Presence of Virion-Associated Host Proteins and Impact of Opportunistic Infection J. Virol., January 1, 2000; 74(1): 139 - 145. [Abstract] [Full Text] |
||||
![]() |
N. J. DePolo, C. E. Harkleroad, M. Bodner, A. T. Watt, C. G. Anderson, J. S. Greengard, K. K. Murthy, T. W. Dubensky Jr., and D. J. Jolly The Resistance of Retroviral Vectors Produced from Human Cells to Serum Inactivation In Vivo and In Vitro Is Primate Species Dependent J. Virol., August 1, 1999; 73(8): 6708 - 6714. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |